Contattaci Contact Us

Dettagli dell'Evento:

TRANSLATIONAL RESEARCH IN PULMONARY FIBROSIS:FROM BEDSIDE TO BENCH AND BACK

19 ottobre 2023 - Giorno 1

  • Opening and Welcome

    Relatore Marco Confalonieri

    Data Intervento 19/10/2023 - 08:30

  • Lessons from IPF pathology

    Relatore Marco Chilosi

    Data Intervento 19/10/2023 - 08:45

  • Lessons from familiar pulmonary fibrosis genetics

    Relatore Nicol Bernardinello

    Data Intervento 19/10/2023 - 09:05

  • Idiopathic pulmonary fibrosis: phenotypes and comorbidities

    Relatore Athol Wells

    Data Intervento 19/10/2023 - 09:25

  • The large field of the progressive fibrosing ILD: similarities and dissimilarities

    Relatore Antonella Caminati

    Data Intervento 19/10/2023 - 09:45

  • Discussion 1

    Relatore -

    Data Intervento 19/10/2023 - 10:05

  • Reducing the risk of exacerbations

    Relatore Kevin R. Flaherty

    Data Intervento 19/10/2023 - 11:00

  • The role of comorbidities in IPF

    Relatore Sergio Harari

    Data Intervento 19/10/2023 - 11:30

  • Real-world and observational studies: which important information for improving IPF patients treatment?

    Relatore M. Bonifazi

    Data Intervento 19/10/2023 - 12:00

  • Discussion 2

    Relatore -

    Data Intervento 19/10/2023 - 12:30

  • An update on pulmonary regeneration and fibrosis pathobiology

    Relatore Saverio Bellusci

    Data Intervento 19/10/2023 - 14:00

  • Discussion 3

    Relatore -

    Data Intervento 19/10/2023 - 14:20

  • The contribution of pulmonary vascular aging to lung repair and pulmonary fibrosis

    Relatore Giovanni Ligresti

    Data Intervento 19/10/2023 - 14:25

  • Discussion 4

    Relatore -

    Data Intervento 19/10/2023 - 14:40

  • Epigenetic reprogramming in distal alveolar epithelial progenitor cell function as targets for IPF therapeutics

    Relatore Claudio Tirelli

    Data Intervento 19/10/2023 - 14:45

  • Discussion 5

    Relatore -

    Data Intervento 19/10/2023 - 15:00

  • Is the decreased rate of decline of lung function still fundamental in the IPF RCTs?

    Relatore Toby Michael Maher

    Data Intervento 19/10/2023 - 15:05

  • Discussion 6

    Relatore -

    Data Intervento 19/10/2023 - 15:20

  • Flt1 produced by lung endothelial cells impairs type II cells transdifferentiation and repair in pulmonary fibrosis

    Relatore Francesco Salton

    Data Intervento 19/10/2023 - 16:50

  • Discussion 7

    Relatore -

    Data Intervento 19/10/2023 - 17:00

20 ottobre 2023 - Giorno 2

  • High-resolution computed tomography imaging for fibrosing ILD: current and future

    Relatore Maurizio Zompatori

    Data Intervento 20/10/2023 - 09:00

  • Discussion 8

    Relatore -

    Data Intervento 20/10/2023 - 09:20

  • The role of confocal laser endomicroscopy in the diagnosis of diffuse parenchymal lung diseases

    Relatore Mathieu Salaün

    Data Intervento 20/10/2023 - 09:25

  • Discussion 9

    Relatore -

    Data Intervento 20/10/2023 - 09:40

  • Syncrotron radiation-based CT for multiscale imaging in pulmonary fibrosi

    Relatore Willi L. Wagner

    Data Intervento 20/10/2023 - 09:45

  • Discussion

    Relatore -

    Data Intervento 20/10/2023 - 10:00

  • Immunomodulatory treatment of interstitial lung disease

    Relatore Fabrizio Luppi

    Data Intervento 20/10/2023 - 11:00

  • Which new drug for ILD/IPF are ready for regulatory approval?

    Relatore Alessandro Sanduzzi Zamparelli

    Data Intervento 20/10/2023 - 11:20

  • New treatments for rheumatoid arthritis associated ILD

    Relatore Robert Vassallo

    Data Intervento 20/10/2023 - 11:40

  • When single-inhaler triple therapy is a preferred option in asthma management?

    Relatore Francesco Menzella

    Data Intervento 20/10/2023 - 12:00

  • Discussion 11

    Relatore -

    Data Intervento 20/10/2023 - 12:00

  • Senolytic drugs for pulmonary fibrosis

    Relatore Jacobo Sellarés

    Data Intervento 20/10/2023 - 14:00

  • Discussion 12

    Relatore -

    Data Intervento 20/10/2023 - 14:20

  • Take home messages and conclusions

    Relatore -

    Data Intervento 20/10/2023 - 14:40

VGFM DATA-LAYER

Area riservata

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte



Nuovi Progetti: MINUTI DIGITALE



Minuti Menarini Online

Abbonati gratis alla rivista cartacea



Fondazione Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Menarini.

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484